Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
View Patent ↗Selective high-frequency spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 100 KHz may be applied to the patient's spinal cord region to address low back pain without creating unwanted sensory and/or motor side effects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.
1. A spinal cord modulation system for treating a patient, the system comprising:
an implantable signal delivery device configured for delivering a therapy signal to one or more locations in the patient's spinal cord region;
a signal generator programmed to generate a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range between 1.5 kHz and 50 kHz at an amplitude that provides pain relief without generating paresthesia; and
wherein the signal generator is in electrical communication with the implantable signal delivery device; and
a power source, wherein the power source is configured to power the signal generator.
2. The system of claim 1 , wherein the signal generator is implantable.
3. The system of claim 1 , wherein the implantable signal delivery device is a percutaneous lead.
4. The system of claim 1 , wherein the implantable signal delivery device is a paddle lead.
5. The system of claim 1 , wherein the power source is configured to transmit power to the signal generator using RF signals.
6. The system of claim 1 , wherein the power source is configured to transmit power to the signal generator via electromagnetic induction.
7. The system of claim 1 , wherein the power source is portable.
8. The system of claim 1 , further comprising:
a wireless programmer, wherein the wireless programmer includes programming functionality to select therapy signal parameters in the signal generator.
9. The system of claim 1 , wherein the implantable signal delivery device delivers the therapy signal to a vertebral level between T9 and T12, inclusive.
10. The system of claim 1 , wherein the implantable signal delivery device includes electrical contacts configured to deliver the therapy signal to a location lateral from the patient's spinal cord so as to be proximate to a dorsal root, dorsal root entry zone, or dorsal root ganglion.
11. The system of claim 1 , wherein the therapy signal amplitude is in an amplitude range between 0.1 mA and 10 mA.
12. A spinal cord modulation system for treating a patient, the system comprising:
a signal generator having one or more processors programmed to generate a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range between 3 kHz and 20 kHz;
an implantable signal delivery device having two or more electrical contacts configured for delivering the therapy signal to one or more locations in the patient's spinal cord region, wherein the implantable signal delivery device is in electrical communication with the signal generator; and
an external power source, wherein the external power source is configured to transmit power to the signal generator via electromagnetic induction.
13. The system of claim 12 , wherein the signal generator is implantable.
14. The system of claim 12 , wherein the implantable signal delivery device is a percutaneous lead.
15. The system of claim 12 , wherein the implantable signal delivery device is a paddle lead.
16. The system of claim 12 , wherein the external power source is configured to transmit power to the signal generator using RF signals.
17. The system of claim 12 , wherein the external power source is portable.
18. The system of claim 12 , further comprising:
a wireless programmer, wherein the wireless programmer includes programming functionality to select therapy signal parameters in the signal generator.
19. The system of claim 12 , wherein the signal generator further comprises executable instructions that, when executed, deliver the therapy signal to a vertebral level between T9 and T12, inclusively.
20. The system of claim 12 , wherein the electrical contacts of the implantable signal delivery device are configured to deliver the therapy signal to a location lateral from the patient's spinal cord so as to be proximate to a dorsal root, dorsal root entry zone, or dorsal root ganglion.
21. The system of claim 12 , wherein the therapy signal amplitude is in an amplitude range between 0.1 mA and 10 mA.
22. A spinal cord modulation system for treating a patient, the system comprising:
a pulse generator having a housing and one or more processors programmed to generate a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal has a frequency in a frequency range between 3 kHz and 15 kHz;
an implantable signal delivery device having one or more electrical contacts configured for delivering the therapy signal to one or more locations in a patient's spinal cord region, wherein the implantable signal delivery device is in electrical communication with the pulse generator; and
an external power source, wherein the external power source is configured to transmit power to the pulse generator via RF signals.
23. The system of claim 22 , wherein the pulse generator is implantable.
24. The system of claim 22 , wherein the implantable signal delivery device is a percutaneous lead.
25. The system of claim 22 , wherein the implantable signal delivery device is a paddle lead.
26. The system of claim 22 , wherein the external power source is portable.
27. The system of claim 22 , wherein the pulse generator is programmed to receive signal parameter updates from a wireless programmer.
28. The system of claim 22 , wherein the pulse generator further comprises executable instructions that, when executed, deliver the therapy signal to a vertebral level between T9 and T12, inclusively.
29. The system of claim 22 , wherein the electrical contacts of the implantable signal delivery device are configured to deliver the therapy signal to a location proximate to a dorsal root, dorsal root entry zone, or dorsal root ganglion.
30. The system of claim 22 , wherein the therapy signal amplitude is in an amplitude range between 0.1 mA and 10 mA.
31. The system of claim 22 , wherein the therapy signal amplitude is in an amplitude range between 1 and 5 mA.